Mycobacterium tuberculosis infection is accompanied by acute and chronic inflammatory infiltrates associated with necrotizing granulomas in lung tissue. The cellular infiltrate is characterized by inflammatory cells which include neutrophils, lymphocytes, and macrophages. In animal and in vitro models of mycobacterial infection, cytokines including tumor necrosis factor-c (TNF-a), interferon gamma (IFNy), and interleukin-1lf participate in granulomatous inflammation. We hypothesized that interleukin-8, a potent chemoattractant for neutrophils and lymphocytes, could be released by activated alveolar macrophages after exposure to M. tuberculosis or its components and contribute to granulomatous lung inflammation. A quantitative immunoassay revealed that IL-8 protein release was significantly elevated in supernatants of macrophages and in lavage fluid obtained from patients with pulmonary tuberculosis compared to normal controls. In addition, Northern blots demonstrated striking up-regulation of IL-8 mRNA in macrophages from these patients. M. tuberculosis and its cell wall components lipoarabinomannan (LAM), lipomannan (LM), and phosphoinositolmannoside (PIM) stimulated IL-8 protein release and mRNA expression in vitro from alveolar macrophages, but deacylated LAM did not. Neutralizing antibodies to TNF-a and/or IL-1-a and P blocked 83% of the stimulation. IL-8 synthesis and release is an early response of macrophages after phagocytosis ofM. tuberculosis. Its production serves to attract both acute and chronic inflammatory cells of active infection and thus participates in the process of containment of the pathogen. (J. Clin. 
Introduction
Tuberculosis is a major cause of morbidity and mortality with approximately 25 million infectious cases reported throughout the world annually (1) (2) (3) . The decline in tuberculosis in the U. S. has been reversed by a new tuberculosis epidemic fueled by the crises of AIDS, intravenous drug use, homelessness, and dismantling of the public health infrastructure for tuberculosis programs (4) . To develop new strategies to treat and prevent tuberculosis, we and others have focused on cytokine networks in the lung to understand more about the human host response (5) (6) (7) (8) . We have previously demonstrated that Mycobacterium tuberculosis and its cell wall components stimulate both mRNA for IL-1,6 and TNF-a and protein release. Transcription is enhanced by the nuclear transcription factor, NF-1L6 (5, (9) (10) . These data are supported by numerous other investigations on the release of these cytokines by M. tuberculosis, yet it is unclear whether in vivo, enhancement or inhibition of select cytokines is propitious (11) (12) (13) (14) (15) (16) (17) for containment of the infection. Friedland and colleagues (18) reported that IL-8 was produced after phagocytosis of M. tuberculosis by a monocytic cell line (THP-1 cells) and proposed that this cytokine was involved in granuloma formation possibly by acting as a T cell chemoattractant. We now demonstrate the in vivo release of IL-8 from alveolar macrophages obtained from patients with active tuberculosis and investigate the mechanism of this release.
IL-8 is a recently characterized cytokine that functions as a chemotactic factor for neutrophils (27), T lymphocytes (28) and basophils (29) . It belongs to a family of 8-kD polypeptides (30, 31 ). Because IL-8 is a chemoattractant for both neutrophils and lymphocytes, it may modulate both acute and chronic inflammation. Neutrophils are sequestered within the lung in granulomatous as well as fibrotic interstitial lung diseases. Sequestration may be induced by IL-8 as well as a number of other chemoattractants including C5a (24), leukotriene B4 (25) and transforming growth factor 3 (26) . Granulomatous diseases are also characterized by an abundance of lymphocytes, many of which are found around the periphery of the granuloma. Thus IL-8, as both a neutrophil and lymphocyte chemoattractant, may be a pivotal cytokine in the control of the inflammatory response to M. tuberculosis. Therefore, overexpression of IL-8 during M. tuberculosis infection may be responsible for the neutrophil and lymphocyte infiltrations which lead to granuloma formation. In ELISA assay for IL-8. The assays were carried out with commercially available kits from R & D System (Minneapolis, MN). For the assay, the frozen supernatants were thawed out at room temperature and added to wells of rigid flat-bottomed microliter plates coated with murine monoclonal antibody to IL-8. After incubation of the samples, horseradish peroxidase (HRP)-conjugated antibody was added to the test wells. After a second incubation, the excess of the HRP-conjugated antibody was removed by washing. IL-8 was quantitated by a microtiter plate reader.
Isolation ofRNA and Northern blot analysis. Normal alveolar macrophages were treated with test reagents for 4 h, collected by centrifugation and lysed by addition of 5.5 M guanidinium isothiocyanate buffer. Fresh alveolar macrophages from patients or controls were also processed directly for RNA extraction. Cytoplasmic RNA was isolated through CsC12 gradient ultracentrifugation. An equal amount of the obtained RNA was fractionated by electrophoresis through a 1% agarose-6% formaldehyde denaturing gel and transferred onto a nitrocellulose filter (BA 85; Schleicher and Schuell, Inc., Keene, NH). The baked filter was prehybridized in a solution containing 50% formamide, 0.5% SDS, lOx Denhardt, 2.5% herring sperm DNA, and 4x SSPE at 420C for 6 h. For hybridization, the IL-8 cDNA (kindly provided by Jan Vilcek M.D. [New York University Medical Center]) was labeled with (alpha-32P) dCTP (specific activity 3,000 Ci/mmol from DuPont-NEN, Boston, MA) by the random-priming technique using the kit purchased from Boehringer Mannheim (Indianapolis, IN). The hybridization was carried out at 42°C overnight. The filter was then washed in a solution containing 2x SSC and 0.5% SDS at room temperature for 20 min followed by O.1 X SSC plus 0.5% SDS at 65°C for 30 min. The filter was exposed at -70°C for 1-3 d.
Statistics. Data were assessed for normal distribution and analyzed with the Student's t test (unpaired) to compare mean IL-8 release and percent neutrophils from patients versus controls. Data was expressed as mean±standard error of the mean. A P value of < 0.05 was considered significant. When data were not normally distributed, nonparametric methods were used including the Wilcoxon test for BAL parameters.
Results
Evaluation of bronchoalveolar lavage for cell profile and IL-8 release. Both the cell concentration and cell differential differed between patients with active pulmonary tuberculosis and normals. Patients with active tuberculosis showed a twofold increase in cellularity (641±165 X 103 cells/ml) versus normals (314±39 X 103 cells/ml). A subgroup of the tuberculosis patients displayed increases in the percentage of lymphocytes or neutrophils (Fig. 1) . Most of the patients with tuberculosis had a striking increase in neutrophils compared to controls (TB patients 37±10% versus normals 1±1%, P < 0.05).
To determine whether alveolar macrophages spontaneously released more IL-8 in patients with tuberculosis, AMs (106/ ml) were cultured for 24 h and supernatants analyzed for IL-8 release. Alveolar macrophages from patients with tuberculosis released significantly more IL-8 into culture supernatants compared with normals (TB patients 87±15 ng/ 106 cells versus normals 9±1 ng/106 cells, P < 0.01, Fig. 2 A) . IL-8 was also increased in the BAL fluid recovered from patients with tuberculosis (2,510±692 pg/mg protein versus normals 549±81 pg/mg protein, P = 0.06, Fig. 2 B) . LPS contamination of BAL fluid was negligible (14-50 pg/ml) and was not different between normals and TB patients. The linear association between the IL-8 in the BAL fluid and the neutrophils per milliliter recovered in the lavage was significant (r2 = 0.74, P < 0.01, Fig. 3 with TB compared with normal controls (Fig. 4) . Thus AMs from patients with tuberculosis secrete increased amounts of IL-8, and this increase was determined in part, by enhanced mRNA expression.
Stimulation of IL-8 protein release and mRNA expression from alveolar macrophages with M. tuberculosis and its cell wall components. To determine the specific mechanism by which IL-8 release was stimulated, we evaluated the ability of (Fig. 6 A) and THP-1 cells (Fig.  6 B) . There was a sixfold greater release of IL-8 from blood monocytes compared with THP-1 cells. LAM and PIM from the M. tuberculosis Erdman strain stimulated minimal release of IL-8. This is consistent with previous reports demonstrating that extensive mannosyl capping is associated with less cytokine release from macrophages (38) . The Hsp-65kD from M. bovis also stimulated minimal release of IL-8. Last, deacylated LAM was unable to stimulate IL-8 release, a finding consistent with previous reports demonstrating the necessity of the phosphoinositol cell wall anchor of LAM to stimulate the release of cytokines (8, 38) . To determine whether IL-8 mRNA level was also increased by M. tuberculosis and its components, we performed Northern blot analysis of normal AM. Whole M. tuberculosis and its components LAM, PIM, and LM from H37Ra as well as Hsp65kD stimulated a significant increase in IL-8 mRNA level in alveolar macrophages after 4 h of stimulation (Fig. 7) .
To demonstrate that these results were not due to contamination with LPS, all test reagents were evaluated for LPS contamination using the Limulus Amebocyte assay. Less than 10 pg/ mg was found for each test reagent (LAM, LM, PIM, Hsp- Figure 6 . Stimulation of IL-8 production from peripheral blood monocytes (A) and THP-1 cells (B) with various stimuli. Cells (106/ml) were stimulated with different stimuli: M. tuberculosis (105/ml), LAM H37Ra (100 ng/ml), LAM Erdman (100 ng/ml), PIM H37Ra (100 ng/ml), LM (100 ng/ml), Hsp-65kD (1 ,ug/ml), and Deacyl LAM (100 ng/ml) for 24 h.
65kD) in all lots tested. To further guard against LPS contamination, the experiments in Figs. 5 and 6 were performed in the presence of polymyxin B 10-100 mg/ml with no significant alteration of the results (data not shown). These doses of polymyxin B completely blocked the stimulatory effect of LPS on IL-8 (14) .
Effect of anti-cytokine antibodies on IL-8 release stimulated by M. tuberculosis. We (6) and others (7) (8) (14) (15) 52±8  26±3  49  38±7  26  20±2  61  PIM H37Ra  43±7  25±3  43  28±5  36  9±1  80  LM H37Ra  60±10  29±5  52  40±8  33  11±3  82 THP-1 cells were plated at 106/ml in 24-well tissue culture plates and stimulated for 24 h with LAM (100 ng/ml), PIM (100 ng/ml), and LM (100 ng/ml) in the absence or presence of antibodies against TNF-a, IL-la, and/or IL-1Ip. The supernatants were collected and IL-8 rlease was measured using IL-8 ELISA. The numbers in the table are calculated with three independent experiments and expressed as mean±SEM.
late the release of TNF-a and IL-1I3, cytokines which also induce IL-8 release in monocytes/macrophages. Thus, we determined whether IL-8 release by M. tuberculosis components was mediated by TNF-a and/or IL-1. The addition of anti-TNF-a and anti-IL-la and anti-IL-l:3 antibodies alone or in combination significantly reduced the release of IL-8 from THP-1 cells after 24 h of stimulation by LAM, PIM, or LM (H37Ra) ( Table  I) . Anti-TNF-a antibody alone blocked the production of IL-8 stimulated by LAM, PIM, or LM by 49, 43 , and 52%, respectively. Neutralizing antibodies against IL-a and , / inhibited IL-8 production by these stimuli to a slightly lesser extent (26, 36, and 33%, respectively). The presence of all three neutralizing antibodies to TNF-a and IL-la and /3 reduced secretion to 61, 80, and 82%, respectively. We performed identical experiments with normal alveolar macrophages and obtained very similar results (Table II) . However, AMs release much more IL-8 than THP-l cells and are similar to peripheral blood monocytes (Fig.  6) We observed exaggerated spontaneous IL-8 release from AMs lavaged from patients with active tuberculosis which was even greater than that seen in the in vitro studies obtained from the avirulent Erdman strain; these results demonstrate the difficulty in modeling the human experience with animal models and laboratory strains of M. tuberculosis. IL-8 is a known chemotactic agent for both neutrophils and T cells at nanomolar and picomolar concentrations respectively; in this regard, IL-8 may be of central importance in granuloma formation and necrotic changes of granulomas (28) . IL-8 has been implicated as a chemotactic factor in bronchoalveolar la- ( 18) . Whereas these investigators observed IL-8 mRNA accumulated gradually over 24 h in THP-1 cells, they found that secretion was identical using virulent or avirulent strains. Using a monoclonal antibody to TNF-a, they also failed to demonstrate a change in IL-8 release.
We have now demonstrated that both AM and PBM release IL-8 in response to M. tuberculosis and Mycobacterium sp. cell wall components. In contrast to Friedland et al., our polyclonal antibody elicited a 47-57% decrease in IL-8 release. Thus AM and PBM release IL-8 in a paracrine/autocrine manner in response to M. tuberculosis. Subcomponents LAM, LM, and PIM, had similar stimulatory capabilities, but removing the phosphoinositol anchor in the cell wall by deacylation abrogated these activities. We found AM released more IL-8 than PBM in response to live M. tuberculosis but similar amounts of IL-8 were released in response to using cell wall components. Both AM and PBM released approximately sixfold more IL-8 than THP-1 cells with each of the stimuli. The difference in the response to LAM between THP-1 cells and AM or PBM may be due to culture differences; THP-1 cells are cultured in suspension whereas AM and PBM are adherent. In addition, cell lines may be less responsive than primary cultures.
Transcripts for mRNA from two receptors for IL-8 have been described in PMN (45-47) and IL-8 binds to two proteins (p70 and p44) with high affinity. Thus the enhanced presence of IL-8 in response to M. tuberculosis may function to recruit and activate neutrophils at sites of pulmonary infections. Jones and colleagues have demonstrated that neutrophils kill M. tuberculosis (48) . The toxic effect is mediated by nonoxidative means because neither free radical inhibitors (catalase, superoxide dismutase) nor deferoxamine impaired killing (48) . Moreover, neutrophils from a patient with chronic granulomatous disease with defective NADPH pathway, were able to kill M. tuberculosis (48) . M. tuberculosis is also capable of producing superoxide dismutase (the 23-kD antigen), and catalase (49) . The 23-kD superoxide dismutase is the major protein released by M. tuberculosis in logarithmic growth constituting a very important factor for virulence (49) . In addition, LAM is a potent scavenger of oxygen radicals (50) . Although neutrophil nonoxidative mechanisms including defensins and bactericidal permeability increasing protein may contribute to host defense, they may be inadequate to control infection of mycobacteria.
Neutrophils in an animal model of pleural TB release chemotaxins for monocytes that may then participate in granuloma formation (51) .
In contrast to neutrophils, lymphocytes express only a single mRNA transcript for IL-8R2 receptor (46) and its expression is less than that in neutrophils. In addition, only a subpopulation of lymphocytes respond to IL-8. These lymphocytes require prior activation and are enriched for CD45RO (47) . Indeed, preincubation of lymphocytes to purified protein derivative of M. tuberculosis results in a phenotypically distinct population of lymphocytes with an enhanced response to IL-8 (52) .
IL-8 may also mediate the healing of granuloma. In a manner similar to basic and acidic fibroblast growth factor, IL-8 is angiogenic and also binds to heparin (53) . Thus IL-8, like TNFa, may participate in the angiogenesis observed in the healing process, particularly that seen at the margin of tuberculosis cavities.
We propose that the release of IL-8, as well as that of TNFa and IL-1,6 from alveolar macrophages is rapid upon ingestion of the M. tuberculosis. These cytokines form an autocrine regulatory loop. Although the neutrophils are rapidly recruited, oxidant and nonoxidant mechanisms of killing may be overwhelmed by M. tuberculosis, LAM and scavenging enzymes. These data demonstrate the enhanced presence of IL-8 in pulmonary tuberculosis in humans. The potent effect of IL-8 on both neutrophils and lymphocytes make this a pivotal cytokine.
